Identifying Common Genetic Variants in Blood Pressure Due to Polygenic Pleiotropy With Associated Phenotypes

Blood pressure is a critical determinant of cardiovascular morbidity and mortality. It is affected by environmental factors, but has a strong heritable component. Despite recent large genome-wide association studies, few genetic risk factors for blood pressure have been identified. Epidemiological studies suggest associations between blood pressure and several diseases and traits, which may partly arise from a shared genetic basis (genetic pleiotropy). Using genome-wide association studies summary statistics and a genetic pleiotropy-informed conditional false discovery rate method, we systematically investigated genetic overlap between systolic blood pressure (SBP) and 12 comorbid traits and diseases. We found significant enrichment of single nucleotide polymorphisms associated with SBP as a function of their association with body mass index, low-density lipoprotein, waist/hip ratio, schizophrenia, bone mineral density, type 1 diabetes mellitus, and celiac disease. In contrast, the magnitude of enrichment due to shared polygenic effects was smaller with the other phenotypes (triglycerides, high-density lipoproteins, type 2 diabetes mellitus, rheumatoid arthritis, and height). Applying the conditional false discovery rate method to the enriched phenotypes, we identified 62 loci associated with SBP (false discovery rate <0.01), including 42 novel loci. The observed polygenic overlap between SBP and several related disorders indicates that the epidemiological associations are not mediated solely via lifestyle factors but also reflect an etiologic relation that warrants further investigation. The new gene loci identified implicate novel genetic mechanisms related to lipid biology and the immune system in SBP.

[1]  O. Andreassen,et al.  Boosting the power of schizophrenia genetics by leveraging new statistical tools. , 2014, Schizophrenia bulletin.

[2]  D. Rujescu,et al.  Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate , 2013, PLoS genetics.

[3]  O. Andreassen,et al.  All SNPs Are Not Created Equal: Genome-Wide Association Studies Reveal a Consistent Pattern of Enrichment among Functionally Annotated SNPs , 2013, PLoS genetics.

[4]  M. McCarthy,et al.  Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. , 2013, American journal of human genetics.

[5]  Daniel L. Koller,et al.  Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture , 2012, Nature Genetics.

[6]  F. Agakov,et al.  Abundant pleiotropy in human complex diseases and traits. , 2011, American journal of human genetics.

[7]  T. Coffman,et al.  Under pressure: the search for the essential mechanisms of hypertension , 2011, Nature Medicine.

[8]  Thomas Meitinger,et al.  Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution , 2011, Nature Genetics.

[9]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[10]  Christian Gieger,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[11]  W. G. Hill,et al.  Genome partitioning of genetic variation for complex traits using common SNPs , 2011, Nature Genetics.

[12]  C. Savopoulos,et al.  Reconsider Hypertension Phenotypes and Osteoporosis , 2011, Journal of clinical hypertension.

[13]  G. Wagner,et al.  The pleiotropic structure of the genotype–phenotype map: the evolvability of complex organisms , 2011, Nature Reviews Genetics.

[14]  P. Doris The genetics of blood pressure and hypertension: the role of rare variation. , 2011, Cardiovascular therapeutics.

[15]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[16]  T. Kurtz Genome-Wide Association Studies Will Unlock the Genetic Basis of Hypertension: Con Side of the Argument , 2010, Hypertension.

[17]  Thomas Meitinger,et al.  Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution , 2010, Nature Genetics.

[18]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[19]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[20]  P. Visscher,et al.  Common SNPs explain a large proportion of heritability for human height , 2011 .

[21]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[22]  Jing Cui,et al.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci , 2010, Nature Genetics.

[23]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[24]  Marit Holden,et al.  Eight genes are highly associated with BMD variation in postmenopausal Caucasian women. , 2010, Bone.

[25]  P. Deloukas,et al.  Multiple common variants for celiac disease influencing immune gene expression , 2010, Nature Genetics.

[26]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[27]  Yun Joo Yoo,et al.  Genome-wide association analyses of North American Rheumatoid Arthritis Consortium and Framingham Heart Study data utilizing genome-wide linkage results , 2009, BMC proceedings.

[28]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[29]  Helen Schuilenburg,et al.  Information for : Genome-wide association study and meta-analysis indicates that over 40 loci affect risk of type 1 diabetes , 2009 .

[30]  L. Sollid,et al.  Antigen presentation in celiac disease. , 2009, Current opinion in immunology.

[31]  F. Vescini,et al.  Salt intake, hypertension, and osteoporosis. , 2009, Journal of endocrinological investigation.

[32]  H. John,et al.  Hypertension in rheumatoid arthritis. , 2008, Rheumatology.

[33]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[34]  C. Bauters,et al.  [Pathophysiology of coronary artery disease]. , 2008, La Revue du praticien.

[35]  B. Efron Size, power and false discovery rates , 2007, 0710.2245.

[36]  Anja Vaskinn,et al.  The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. , 2007, The Journal of clinical psychiatry.

[37]  Radu V. Craiu,et al.  Stratified false discovery control for large‐scale hypothesis testing with application to genome‐wide association studies , 2006, Genetic epidemiology.

[38]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[39]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[40]  B. Rosner,et al.  Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States , 1993, Pediatric Nephrology.

[41]  J. Norris,et al.  Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study , 2003, BMC Genetics.

[42]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[43]  F. Netter,et al.  Supplemental References , 2002, We Came Naked and Barefoot.

[44]  Anita L. DeStefano,et al.  Evidence for a Gene Influencing Blood Pressure on Chromosome 17: Genome Scan Linkage Results for Longitudinal Blood Pressure Phenotypes in Subjects From the Framingham Heart Study , 2000, Hypertension.

[45]  P. Hamet,et al.  Genetic determinants of hypertension: identification of candidate phenotypes. , 2000, Hypertension.

[46]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[47]  G GUIMARAES,et al.  Essential hypertension , 1950, Revue de medecine aeronautique.